NaviCam Patency Capsule to Verify Gastrointestinal Patency
Not applicable · Testing NaviCam Patency Capsule · 1 site · AnX Robotica Corp.
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing NaviCam Patency Capsule (a device) as a screening approach. Condition(s) listed: Intestinal Stricture, Crohn Disease and NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy.
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 22 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months.
- Patients suffering from Crohn's Disease
- Patients with long-term use of non-steroidal anti-inflammatory drugs.
Plus 5 more requirement(s). There are also 7 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 25 participants are expected to take part.
- Start date: 2026-06-15 (planned).
- Main results expected around 2026-12-15 (estimate from the record).
- 1 study site listed in United States.
Main thing being measured
- Safety of patency capsule (30 hours)
In the researchers’ words
Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Intestinal Stricture; Crohn Disease; NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy; Abdominal Pain |
| Lead sponsor | AnX Robotica Corp. |
| Enrollment | 25 (estimated) |
| Start date | 2026-06-15 |
| Primary completion (est.) | 2026-12-15 |
| First posted | 2026-06-16 |
| Last updated | 2026-06-16 |
| Official title | A Prospective, Single Center Clinical Trial Assessing the Efficacy and Safety of the NaviCam Patency Capsule to Verify Gastrointestinal Patency |
| ClinicalTrials.gov ID | NCT07649720 |
Interventions
- NaviCam Patency Capsule (Device)
The NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency of the gastrointestinal tract prior to administration of the NaviCam capsule in patients with known or suspected strictures.
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months. * Patients suffering from Crohn's Disease * Patients with long-term use of non-steroidal anti-inflammatory drugs. * Patients with abdominal symptoms related to intestinal stricture. * Patients with chronic inflammatory diseases. * Patients with difficulty with balloon-assisted endoscopy (BAE). * Patients with a history of small bowel obstruction. * Patients with a history of intestinal resection surgery. Exclusion Criteria: * Patients with esophageal obstruction or swallowing disorder diseases. * Patients who are ineligible for surgery or refuse to undergo any abdominal surgery. * Patients with known allergies or other contraindications or intolerance to the medications used in this study. * Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators. * Pregnant women * Patients currently enrolled in another drug or device clinical trial. * Other conditions deemed unsuitable for inclusion by the investigator.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Digestive Health Services | Downers Grove, Illinois | United States |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.